Clinical Trials Directory

Trials / Conditions / Chronic Pulmonary Aspergillosis

Chronic Pulmonary Aspergillosis

17 registered clinical trials studyying Chronic Pulmonary Aspergillosis — 8 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingDeposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA)
NCT07530263
Radboud University Medical CenterPhase 1
RecruitingRezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options
NCT06794554
Mundipharma Research LimitedPhase 2
RecruitingiMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine
NCT06244979
Radboud University Medical CenterPhase 2
RecruitingImpact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
NCT06885905
Imperial College London—
RecruitingA Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chroni
NCT06447402
Post Graduate Institute of Medical Education and Research, ChandigarhPhase 3
RecruitingInterferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study
NCT05653193
Manchester University NHS Foundation TrustPhase 2
RecruitingOral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndr
NCT05444946
Post Graduate Institute of Medical Education and Research, ChandigarhN/A
UnknownPharmacological Evaluation of Antifungal in Chronic Pulmonary Aspergillosis
NCT05064605
Assistance Publique - Hôpitaux de Paris—
CompletedA Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazo
NCT04824417
Post Graduate Institute of Medical Education and Research, ChandigarhPhase 3
Active Not RecruitingPulmonary Aspergillosis in Tuberculosis Patients
NCT05045391
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan—
CompletedSix Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPA
NCT03920527
Post Graduate Institute of Medical Education and Research, ChandigarhPhase 3
RecruitingChronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole
NCT03656081
Poitiers University HospitalPhase 3
CompletedStudy to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractor
NCT03059992
Scynexis, Inc.Phase 3
UnknownAspergillus-specific IgG Assays for the Diagnosis of Chronic Pulmonary Aspergillosis (CPA)-Multicenter Study
NCT03027089
Chinese PLA General Hospital—
UnknownImpact of A. Lumbricoides on Pulmonary Aspergillosis Development
NCT05783544
Research Institute of Epidemiology, Microbiology and Infectious Diseases, UzbekistanN/A
Active Not RecruitingVitamin D and Immune Response in Pulmonary Tuberculosis With and Without Chronic Pulmonary Aspergillosis
NCT07516158
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan—
No Longer AvailableVoriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis
NCT05897294
TFF Pharmaceuticals, Inc.—